Undervalued Drug Manufacturer Stocks on NAS April 2025

April 20, 2025

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
IRWD Ironwood Pharmaceuticals 0.73 3.05 320.08 4466785 116 0.00 72.7
TLRY Tilray Brands 0.45 1.24 175.28 26290753 409 0.00 0.0
SBFM Sunshine Biopharma 1.25 3.22 157.73 3332442 1 0.00 0.0
TXMD TherapeuticsMD 1.01 2.37 135.06 44120 12 0.00 0.0
ASRT Assertio Holdings 0.61 1.37 125.10 486237 58 0.00 0.0
EVOK Evoke Pharma 2.15 4.82 124.03 27006 4 0.00 0.0
UPC Universe Pharmaceuticals 3.56 7.32 105.68 253171 0 0.00 0.0
FLGC Flora Growth 0.54 1.08 101.05 167284 7 0.00 0.0
AMPH Amphastar Pharma 23.35 45.61 95.35 717636 1216 0.00 7.6
EVO Evotec 3.60 6.60 83.22 115898 1277 0.00 0.0
All data provided as at market close April 16, 2025.

Company Details

Ironwood Pharmaceuticals

IRWD:NAS

Close Price

0.73

Our Valuation

3.05

% Difference

320.08

Market Cap ($M)

116

P/E Ratio

72.7

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases.

Access the stockcalc valuation


Tilray Brands

TLRY:NAS

Close Price

0.45

Our Valuation

1.24

% Difference

175.28

Market Cap ($M)

409

P/E Ratio

0.0

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Access the stockcalc valuation


Sunshine Biopharma

SBFM:NAS

Close Price

1.25

Our Valuation

3.22

% Difference

157.73

Market Cap ($M)

1

P/E Ratio

0.0

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.

Access the stockcalc valuation


TherapeuticsMD

TXMD:NAS

Close Price

1.01

Our Valuation

2.37

% Difference

135.06

Market Cap ($M)

12

P/E Ratio

0.0

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Assertio Holdings

ASRT:NAS

Close Price

0.61

Our Valuation

1.37

% Difference

125.10

Market Cap ($M)

58

P/E Ratio

0.0

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Access the stockcalc valuation


Evoke Pharma

EVOK:NAS

Close Price

2.15

Our Valuation

4.82

% Difference

124.03

Market Cap ($M)

4

P/E Ratio

0.0

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Access the stockcalc valuation


Universe Pharmaceuticals

UPC:NAS

Close Price

3.56

Our Valuation

7.32

% Difference

105.68

Market Cap ($M)

0

P/E Ratio

0.0

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies.

Access the stockcalc valuation


Flora Growth

FLGC:NAS

Close Price

0.54

Our Valuation

1.08

% Difference

101.05

Market Cap ($M)

7

P/E Ratio

0.0

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries).

Access the stockcalc valuation


Amphastar Pharma

AMPH:NAS

Close Price

23.35

Our Valuation

45.61

% Difference

95.35

Market Cap ($M)

1216

P/E Ratio

7.6

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers.

Access the stockcalc valuation


Evotec

EVO:NAS

Close Price

3.60

Our Valuation

6.60

% Difference

83.22

Market Cap ($M)

1277

P/E Ratio

0.0

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Ironwood Pharmaceuticals and Tilray Brands are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-april-2025
Ironwood Pharmaceuticals $IRWD and Tilray Brands $TLRY are the most undervalued Drug Manufacturers stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-april-2025
Ironwood Pharmaceuticals and Tilray Brands are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-april-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.